Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.


Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 13 7 2019
medline: 16 1 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

The objective of this study was to investigate possible differences in treatment responses between two categories for the onset of lupus nephritis. We performed a multicentre, retrospective cohort study of class III-V lupus nephritis patients diagnosed between 1997 and 2014. The renal responses to initial induction therapy were compared between patients who developed lupus nephritis within one year from diagnosis of systemic lupus erythematosus (early (E-) LN) and the remainder (delayed (D-) LN) using the Kaplan-Meier method. We determined the predictors of renal response as well as renal flares and long-term renal outcomes using multivariate Cox regression analyses. A total of 107 E-LN and 70 D-LN patients were followed up for a median of 10.2 years. Log-rank tests showed a lower cumulative incidence of complete response in D-LN compared with E-LN patients. Multivariate analysis identified D-LN (hazard ratio (HR) 0.48, 95% confidence interval (CI) 0.33-0.70), nephrotic syndrome at baseline, and a chronicity index greater than 2 as negative predictors of complete response. D-LN patients were more likely to experience renal flares. D-LN (HR 2.54, 95% CI 1.10-5.83) and decreased renal function were significant predictors of chronic kidney disease at baseline. D-LN was a predictor of poorer treatment outcomes, in addition to renal histology and severity of nephritis at lupus nephritis onset.

Identifiants

pubmed: 31296139
doi: 10.1177/0961203319860200
pmc: PMC6681441
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1062-1073

Commentaires et corrections

Type : ErratumIn

Références

Kidney Int. 2001 Jun;59(6):2156-63
pubmed: 11380817
Arthritis Rheum. 2002 Apr;46(4):995-1002
pubmed: 11953977
Lupus. 2002;11(3):152-60
pubmed: 12004788
Am J Med. 2002 Jun 15;112(9):726-9
pubmed: 12079714
Arthritis Rheum. 2002 Aug;46(8):2121-31
pubmed: 12209517
Ann Rheum Dis. 2003 Jun;62(6):556-60
pubmed: 12759294
Medicine (Baltimore). 2003 Sep;82(5):299-308
pubmed: 14530779
J Am Soc Nephrol. 2004 Feb;15(2):241-50
pubmed: 14747370
Arthritis Rheum. 2004 Aug;50(8):2559-68
pubmed: 15334470
Kidney Int. 2004 Dec;66(6):2382-8
pubmed: 15569330
Arthritis Rheum. 2004 Dec;50(12):3934-40
pubmed: 15593207
Autoimmunity. 2005 Feb;38(1):47-54
pubmed: 15804705
Lupus. 2005;14(11):890-5
pubmed: 16335581
Lupus. 2006;15(12):845-51
pubmed: 17211989
Clin J Am Soc Nephrol. 2008 Jan;3(1):46-53
pubmed: 18003764
Rheumatology (Oxford). 2008 May;47(5):702-7
pubmed: 18390590
Ann Rheum Dis. 2008 Jul;67(7):1044-6
pubmed: 18413438
Mod Rheumatol. 2009;19(3):293-301
pubmed: 19277827
Nat Rev Nephrol. 2009 Apr;5(4):212-20
pubmed: 19322186
Clin J Am Soc Nephrol. 2009 Dec;4(12):1962-7
pubmed: 19820130
Arthritis Care Res (Hoboken). 2010 Jun;62(6):873-80
pubmed: 20191478
Ann Rheum Dis. 2011 Jan;70(1):151-6
pubmed: 20881011
Arthritis Care Res (Hoboken). 2011 Mar;63(3):351-7
pubmed: 21080348
PLoS Genet. 2011 Feb;7(2):e1001311
pubmed: 21379322
J Rheumatol. 2011 Dec;38(12):2588-97
pubmed: 21965650
J Rheumatol. 2012 Jan;39(1):79-85
pubmed: 22089455
Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808
pubmed: 22556106
Ann Rheum Dis. 2012 Nov;71(11):1771-82
pubmed: 22851469
J Rheumatol Suppl. 1987 Jun;14 Suppl 13:188-93
pubmed: 2441045
Lupus. 2014 Oct;23(11):1124-32
pubmed: 24860121
Arthritis Rheumatol. 2015 May;67(5):1305-13
pubmed: 25605554
Arthritis Rheumatol. 2016 Jun;68(6):1432-41
pubmed: 26815601
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i67-i77
pubmed: 27940583
Arthritis Res Ther. 2017 Jan 13;19(1):4
pubmed: 28086993
J Rheumatol. 2018 Apr;45(4):513-520
pubmed: 29449502
Semin Arthritis Rheum. 2018 Dec;48(3):462-466
pubmed: 29566965
Lupus. 2019 Jan;28(1):123-128
pubmed: 30442061
Am J Med. 1983 Sep;75(3):382-91
pubmed: 6351607
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
Kidney Int. 1994 Feb;45(2):544-50
pubmed: 8164443
Kidney Int. 1996 Dec;50(6):2047-53
pubmed: 8943489
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Clin Rheumatol. 1998;17(6):468-77
pubmed: 9890674

Auteurs

M Nakano (M)

1 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

K Kubo (K)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Y Shirota (Y)

3 Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Y Iwasaki (Y)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Y Takahashi (Y)

1 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

T Igari (T)

4 Pathology Division of Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, Japan.

Y Inaba (Y)

5 Biostatistics Section, Department of Clinical Research and Informatics, Clinical Science Center, National Center for Global Health and Medicine, Tokyo, Japan.

Y Takeshima (Y)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
6 Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

S Tateishi (S)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
7 Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

H Yamashita (H)

1 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

M Miyazaki (M)

8 Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

H Sato (H)

9 Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan.

H Kanda (H)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
7 Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

H Kaneko (H)

1 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

T Ishii (T)

3 Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
10 Clinical Research, Innovation and Educational Center, Tohoku University Hospital, Sendai, Japan.

K Fujio (K)

2 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

N Tanaka (N)

5 Biostatistics Section, Department of Clinical Research and Informatics, Clinical Science Center, National Center for Global Health and Medicine, Tokyo, Japan.

A Mimori (A)

1 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH